NCT00233532View on ClinicalTrials.gov

Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)

PHASE4CompletedINTERVENTIONAL

Enrollment

2,000

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

June 30, 2005

Conditions

Hypertension

Interventions

DRUG

Trandolapril

0.5, 1,2,4mg/once daily/ for 26 weeks (If BP was not controlled, dose was escalated to the next higher dosage every 4-5 weeks).

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Abbott

INDUSTRY